Yabao and South Australia University sign collaboration agreement to identify treatments for cancer.
China-based pharmaceutical firm Yabao is to partner South Australia University (SAU) on a collaboration to find new treatments for cancer.
The two organisations will be working together in a co-funded laboratory with Yabao providing contributions of an undisclosed size in return for exclusive rights to develop and commercialise any potential drugs within China. SAU will retain commercialisation rights for markets outside of China.
David Lloyd, vice chancellor of SAU, said: “We are thrilled to have forged such a strong collaboration in China that will enhance the development of new therapies for cancer, a disease that continues to present one of our greatest global challenges.”
